造影マンモグラフィ市場規模、シェア、成長分析：用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

造影マンモグラフィの市場規模は2023年に23億米ドルで、2024年の24億4,000万米ドルから2032年には38億9,000万米ドルに拡大し、予測期間（2025-2032年）のCAGRは6.0％で成長する見通しです。

造影マンモグラフィ（CEM）は、デュアルエネルギー技術を活用することで、デジタルマンモグラフィと静脈内造影の利点を効果的に融合し、診断シナリオにおいてフルフィールドデジタルマンモグラフィ（FFDM）や超音波と比較して、乳がん検出において優れた感度を示します。加齢、肥満、家族歴などの危険因子によって悪化する乳がんの世界の有病率の上昇を考えると、CEMの人気は急上昇し、今や主要な画像診断技術となっています。主に女性が罹患する乳がん症例の大半は、大きな市場需要を際立たせています。乳房のしこり、大きさや形の変化、分泌液のような症状は、効果的な検出ソリューションの緊急性を強調しています。その結果、乳がんの罹患率の増加は、先端画像技術の市場成長を推進し続けています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

造影マンモグラフィ市場規模：用途別& CAGR（2025-2032）

• 市場概要
• スクリーニング
• 診断

造影マンモグラフィ市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 診断センター
• 専門クリニック
• その他

造影マンモグラフィ市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• GE Healthcare（USA）
• Siemens Healthineers（Germany）
• Hologic, Inc.（USA）
• Fujifilm Holdings Corporation（Japan）
• Canon Medical Systems Corporation（Japan）
• Philips Healthcare（Netherlands）
• Carestream Health（USA）
• Konica Minolta, Inc.（Japan）
• Planmed Oy（Finland）
• Sectra AB（Sweden）
• Gamma Medica-Ideas, Inc.（USA）
• SuperSonic Imagine（France）
• iCAD, Inc.（USA）
• ScreenPoint Medical（Netherlands）
• DeepHealth（USA）
• Lunit Inc.（South Korea）
• CureMetrix, Inc.（USA）
• Bracco Imaging S.p.A.（Italy）
• Guerbet（France）

結論と提言

Contrast Enhanced Mammography Market size was valued at USD 2.3 billion in 2023 and is poised to grow from USD 2.44 billion in 2024 to USD 3.89 billion by 2032, growing at a CAGR of 6.0% during the forecast period (2025-2032).

By leveraging a dual-energy technique, Contrast-Enhanced Mammography (CEM) effectively merges the advantages of digital mammography with intravenous contrast, showcasing superior sensitivity in breast cancer detection compared to Full-Field Digital Mammography (FFDM) and ultrasound in diagnostic scenarios. Given the escalating global prevalence of breast cancer-exacerbated by risk factors such as age, obesity, and a family history of the disease-CEM has surged in popularity and is now a leading imaging technique. The majority of breast cancer cases, primarily affecting females, highlight significant market demand. Symptoms like breast lumps, changes in size and shape, and fluid discharge underscore the urgency for effective detection solutions. Consequently, the increasing incidence of breast cancer continues to propel market growth for advanced imaging technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Contrast Enhanced Mammography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Contrast Enhanced Mammography Market Segments Analysis

Global Contrast Enhanced Mammography Market is segmented by Applications, End User and region. Based on Applications, the market is segmented into Screening and Diagnosis. Based on End User, the market is segmented into Hospital, Diagnostic Centres, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Contrast Enhanced Mammography Market

The Contrast Enhanced Mammography market is primarily driven by the increasing prevalence of breast cancer, which stands as the most frequently diagnosed cancer among women globally. Early detection of breast cancer significantly enhances treatment efficacy, allowing for improved patient outcomes. Typically, treatment regimens for breast cancer patients encompass a combination of surgery, radiation therapy, and various medications, including hormone therapy, chemotherapy, and targeted biological therapies. These interventions are crucial in managing the disease, as they not only halt the progression of cancer but also reduce the risk of metastasis, ultimately contributing to higher survival rates and better quality of life for affected individuals.

Restraints in the Contrast Enhanced Mammography Market

The Contrast Enhanced Mammography market faces several significant barriers that could hinder its growth and adoption. Firstly, being a relatively novel technology, the costs associated with the equipment, materials, and necessary training are considerably higher than those for traditional mammography, posing a financial challenge for healthcare providers. Additionally, the limited availability of facilities offering this advanced imaging technique makes it difficult for patients, especially in rural or remote regions, to access these services. Furthermore, obtaining regulatory approval for clinical use is often a lengthy and costly process, potentially delaying market entry. Lastly, despite the encouraging results from clinical studies, the absence of long-term data on the technology's safety and effectiveness may lead some healthcare professionals to exercise caution in embracing this advancement until more substantial evidence is presented.

Market Trends of the Contrast Enhanced Mammography Market

The Contrast Enhanced Mammography (CEM) market is experiencing robust growth, driven by the increasing incidence of breast cancer among women and the demand for advanced diagnostic techniques. As healthcare providers adopt state-of-the-art technologies for early detection, CEM stands out for its superior sensitivity and specificity compared to traditional methods. This trend is fueled by the desire for more accurate and timely results, enabling better treatment decisions. Enhanced imaging technologies not only improve diagnostic performance but also instill greater confidence among patients and healthcare professionals, ultimately propelling market expansion and innovation in breast cancer management solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Contrast Enhanced Mammography Market Size by Applications & CAGR (2025-2032)

• Market Overview
• Screening
• Diagnosis

Global Contrast Enhanced Mammography Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospital
• Diagnostic Centres
• Specialty Clinics
• Others

Global Contrast Enhanced Mammography Market Size & CAGR (2025-2032)

• North America (Applications, End User)
  • US
  • Canada
• Europe (Applications, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Applications, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Applications, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Applications, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carestream Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Konica Minolta, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Planmed Oy (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sectra AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gamma Medica-Ideas, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SuperSonic Imagine (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iCAD, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScreenPoint Medical (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DeepHealth (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lunit Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CureMetrix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco Imaging S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guerbet (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations